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Abstract
Background: Uteroglobin-Related Protein 1 (UGRP1) is a secretoglobulin protein which has been suggested to play
a role in lung inflammation and allergic diseases. UGRP1 has also been shown to be an important pneumoprotein,
with diagnostic potential as a biomarker of lung damage. Previous genetic studies evaluating the association
between variations on UGRP1 and allergic phenotypes have yielded mixed results. The aim of this present study
was to identify genetic polymorphisms in UGRP1 and investigate if they were associated with asthma and allergic
rhinitis in the Singapore Chinese population.
Methods: Resequencing of the UGRP1 gene was conducted on 40 randomly selected individuals from Singapore
of ethnic Chinese origin. The polymorphisms identified were then tagged and genotyped in a population of 1893
Singapore Chinese individuals. Genetic associations were evaluated in this population comparing 795 individuals
with allergic rhinitis, 718 with asthma (of which 337 had both asthma and allergic rhinitis) and 717 healthy controls
with no history of allergy or allergic diseases.
Results: By resequencing the UGRP1 gene within our population, we identified 11 novel and 16 known single
nucleotide polymorphisms (SNPs). TagSNPs were then genotyped, revealing a significant association between
rs7726552 and allergic rhinitis (Odds Ratio: 0.81, 95% Confidence Interval: 0.66-0.98, P = 0.039). This association
remained statistically significant when it was analyzed genotypically or when stratified according to haplotypes.
When variations on UGRP1 were evaluated against asthma, no association was observed.
Conclusion: This study documents the association between polymorphisms in UGRP1 and allergic rhinitis,
suggesting a potential role in its pathogenesis.
Background
Allergic diseases such as asthma, allergic rhinitis and
atopic dermatitis are global health problems affecting
10-25% of the world’s population. Allergic rhinitis (AR)
is an IgE-mediated inflammatory disease of the nasal
mucosa which is caused by exposure to allergens. AR is
characterized by hyper-responsiveness, high levels of
Th2 cells [1] and manifestation of symptoms such as
rhinorrhea, sneezing, nasal congestion and rhino-con-
junctivitis. AR affects approximately 500 million people
worldwide [2,3]. In Singapore, the prevalence of AR was
reported to be 13.1% [4]. AR is not a life threatening
disease; however its impact on the quality of life and
productivity is significant [3,5]. In addition, AR is
known to be associated with other conditions such as
asthma, sinusitis, anosmia, otitis media, nasal polyps,
lower airway infections and dental malocclusion [2,6-8].
Many reports support a genetic basis for atopy and
allergy [9,10]. The underlying pathogenic mechanism of
allergic diseases is not fully elucidated and may be the
result of complex interactions between genetic and
environmental factors [2,6]. Studies looking at twins
have provided convincing evidence for a genetic influ-
ence, as observed by the greater concordance of allergic
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manifestations in monozygotic compared to dizygotic
twins [11-14]. Non-genetic factors such as an increase
in exposure to irritants and allergens, changes in life-
style, nutrition, pollution and stress, may also influence
the onset and development of atopic diseases [7,15-17].
Individuals with a strong family history of allergic dis-
ease are more likely to develop allergic symptoms, irre-
spective of the varying environmental risk factors across
societies [15,18].
The gene coding for secretoglobulin (SCGB3A2), also
known as UGRP1, is located within chromosome 5q31-
33. This region of the human chromosome 5 also con-
tains many other candidate genes for allergic diseases
such as interleukins - IL-3, IL-4, IL-5, IL-9, IL-13;
macrophage colony stimulating factor (CSF) and
b2-adrenergic receptor (ADRB2) [19]. Genetic variations
in UGRP1 have been associated with autoimmune dis-
eases such as Hashimoto thyroiditis (HT) and Graves’
disease (GD) [20], and allergic diseases such as asthma
[21]. A promoter polymorphism in the gene (G-112A)
was found to increase the risk of asthma in a Japanese
population [19]. However, the association was not repli-
cated in studies involving Indians [22] and German Cau-
casians [23]. There has not been any association study
evaluating the role of these polymorphisms in AR to
date. In Singapore a family based linkage study had pre-
viously identified the 5q31-33 region to be significantly
linked to atopy and asthma in the local ethnic Chinese
population [24]. As part of a larger study to fine-map
candidate genes for atopy and asthma in this chromo-
some region, resequencing of the UGRP1 gene was per-
formed, with the aim of identifying novel
polymorphisms in Singapore Chinese and evaluating
their association to allergic rhinitis and asthma.
Methods
Ethics Statement
This study has been performed with the approval of the
Institutional Review Board (IRB, Reference - NUS07-023
and NUS10-343) of the National University of Singapore
and is in compliance with the Helsinki declaration.
Study Population
Ethnic Chinese subjects were recruited at the National
University of Singapore, KK Women’s and Children
Hospital and the National University Hospital as a part
of an on-going epidemiological collection for the study
of allergic diseases and through multiple recruitment
drives in Singapore (Table 1). Those not born in
Singapore and did not reside locally in the past 10 years
were excluded. Volunteers were then classified as indivi-
duals with AR, asthma and healthy controls according to
their status as determined by an interviewer-administered
questionnaire based on the Allergic Rhinitis Impact on
Asthma (ARIA) and International Study of Asthma and
Allergies in Childhood (ISAAC) guidelines [2,6], and a
doctor’s diagnosis. The validity and use of ARIA- and
ISAAC-based questionnaires has been discussed by others
groups [25,26] and ours as well [27]. In addition, all
volunteers were subjected to a skin prick test (SPT) using
a panel consisting of common allergens in Singapore
such as Dermatophagoides pteronyssinus (house dust
mite), Blomia tropicalis (dust mite), Elaeis guineensis
(pollen) and Curvularia lunata (fungi). A SPT response
is considered positive when the wheal diameter is 3 mm
or greater, when compared to positive (histamine) and
negative (saline) controls. The selection of these allergens
was based on previous studies in the region which clearly
demonstrated that sensitization of the major indoor aller-
gen - the house dust mite (HDM), was considered an
important risk factor for the development of asthma and
allergic diseases, especially in South East Asian popula-
tions, such as those from Singapore, Malaysia and Thai-
land [28-30]. Based on our previous epidemiological
studies [31,32], the majority of AR and atopic asthma
individuals would be sensitized to one or both of the
major dust mites evaluated (Dermatophagoides pteronyssi-
nus, and/or Blomia tropicalis) and up to 30% would be
poly-sensitized (to dust mites and pollen and/or fungal
allergens). Atopy was defined as a positive SPT response
to either dust mite allergen extracts, with or without
poly-sensitization to other allergens. AR was diagnosed
based on the presence of the atopic status and typical AR
symptoms as defined by the ARIA 2008 guidelines [2,6],
i.e., two or more AR symptoms (nasal congestion, rhinor-
rhea, nasal itching, sneezing) persisting for four or more
days a week during the past year. Asthma was classified
based on a positive doctor-diagnosed asthma with wheez-
ing symptoms and positive skin prick responses to
Table 1 Demographic and clinical characteristics of the
samples used in the study
Asthma# Allergic Rhinitis (AR)$ Healthy controls^
Subjects 718 795 717
Age, mean 20.24 21.06 22
Gender
Male 377 (52.5%) 385 (48.4%) 196 (27.3%)
Female 341 (47.5%) 410 (51.6%) 521 (72.7%)
#an asthma case was classified based on doctor diagnosis of the disease with
a positive skin prick test reaction to one of the allergens tested (based on
WHO and GINA guidelines for asthma).
$Allergic Rhinitis (AR) was classified based on 2 or more major symptoms
which include (nasal congestion, rhinorrhea, nasal itching, sneezing) and a
positive skin prick test reaction to one of the allergens tested (based on 2008
guidelines set by Allergic Rhinitis Impact on Asthma (ARIA) consortium).
^Healthy controls are individuals classified based on no symptoms or history
of allergic disease and are non- atopic (Negative skin prick test reaction to
ALL of the allergens).
Note: All samples have been age-category matched.
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common allergens. A subset of the asthmatic individuals
would have complete ACT (Asthma Control Test) scores,
lung function and peak flow reversibility data. (This is
however currently on-going, and thus not reported in
this study). Conversely, healthy control individuals were
defined as those with no atopy (i.e., skin prick negative)
and with no history of allergic conditions, diagnosis, or
symptoms.
Resequencing
Genomic DNA was extracted from buccal cells obtained
from 15 ml of mouthwash in 0.9% saline solution as
previously described [33]. DNA was then quantified
using Nanodrop and by flourimetric analysis using Pico-
Green (Molecular Probes, Invitrogen, OR, USA). DNA
from a subset of 40 randomly selected individuals was
used for sequencing and the identification of genetic
polymorphisms [34]. The 3 exons and exon-intron
boundaries of UGRP1 were sequenced (Additional File
1). Information on primer sequences and the regions
covered by resequencing have been described below in
Additional File 2.
Genotyping
Genotyping was performed on the Illumina BeadXpress
platform (Illumina Inc., San Diego, CA, USA) at the Uni-
versity of Utah Genomics Core Facility (Salt Lake City,
UT, USA) according to manufacturer’s recommendations.
Statistical Analysis
Linkage Disequilibrium (LD) blocks were generated with
the SNPs identified using Haploview v4.2 [26]. Hardy-
Weinberg equilibrium (HWE) was assessed in the con-
trol population as a quality control measure. Tests for
association were performed at the allelic, genotypic and
haplotypic levels and odds ratio with 95% confidence
intervals were estimated by PLINK v1.06. A P-value less
than 0.05 were considered statistically significant (with
Bonferroni corrections for multiple testing where
necessary).
In silico analysis using bioinformatics tools
In silico analysis was performed using bioinformatics
tools such as TRANSFAC, http://www.gene-regulation.
com/cgi-bin/pub/databases/transfac/search.cgi and
TFSEARCH http://www.cbrc.jp/research/db/TFSEARCH.
html to predict potential transcription factor binding site
(TFBS) and possible effects of the polymorphisms on the
binding of transcription factors. The results were cross
compared using another transcription factor prediction




Of the 27 polymorphisms identified through resequen-
cing of the UGRP1 gene [23 SNPs and 4 INDELs
(INsertion/DELetion)], 11 were novel (Additional File 3).
Of the 16 polymorphisms previously reported in NCBI,
only 4 SNPs were present in the HapMap database for
the Han Chinese (CHB) population. LD blocks were
constructed using r2 values estimated for all SNPs iden-
tified through the resequencing of the UGRP1 gene
(Figure 1). Tagging was performed using an LD thresh-
old of r2 = 0.8 resulting in a total of 11 tagSNPs repre-
senting the variations in UGRP1 among Singapore
Chinese. (Additional File 4)
Single SNP marker association analysis
A total of 10 out of the 11 tag SNPs in UGRP1 (Figure 2),
targeted for genotyping, passed the BeadXpress assay
design quality control and were successfully genotyped in
1893 samples (with a genotyping success rate of 99.6%).
Allele based association analyzed using the Cochran Armi-
tage trend test for the AR phenotype revealed that
rs7726552 is significantly associated (Ptrend = 0.032,
OR = 0.81) (Table 2). Association at the genotype level
appeared stronger with Pgenotype = 0.00085 and OR = 0.79
(PBonferroni = 0.0085) (Table 3). No significant association
was detected for the asthma phenotype (Additional File 5).
Haplotype based association analysis
Haplotypes within UGRP1 were tested for significant
associations with the atopic conditions using PLINK.
The haplotype H2 (ATGGTGC), covering a region of
4.13 kb, encompassing the promoter and the first intron,
and consisted of the SNPs rs7726552, rs7727031,
UGRP1-G-1351A, rs6882292, rs17107353, rs17703574
and UGRP1-C1360A, was found to be the most com-
mon with a frequency of 69.6% in controls and 65.5% in
cases (P = 0.017) (Table 4). These results are consistent
with the single SNP association of rs7726552 with AR,
and where the allele frequencies were 14% in cases and
17% in controls (P = 0.039).
In silico prediction of putative function
TRANSFAC was used to predict possible TFBS which
might be affected due to the SNP. The in silico prediction
tool revealed that the region containing SNP rs7726552
has potential consensus binding sites for transcription fac-
tors Oct-1, NF-1 and GATA-1. The A to T polymorphism
was predicted to result in a new binding site for GATA-1,
the loss of binding site for Oct-1 and no change in tran-
scription factor binding for NF-1. Similar results were also
shown using TFBS software ALIBABA 2.1.
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Discussion
UGRP1 was originally suggested to have an anti-inflam-
matory function due to its similarity to uteroglobin/
Clara cell secretory protein [21]. UGRP1 is localized in
the chromosome 5q31-32 region where asthma suscept-
ibility locus has been assigned [35] and the high expres-
sion of this protein in epithelial cells of the airway [21]
suggests a possible role in allergic airway inflammation.
Further evidence of the role of UGRP1 is seen in its reg-
ulation by various T-regulatory cytokines such as IL-10
[36], IL-5 and IL-9 [37,38], suggesting its involvement in
allergic response. Claire et al., have shown that there is
an increase in UGRP1 in the induced sputum of patients
with asthma and rhinitis, further suggesting a possible
role in inflammatory diseases [39].
The SNP rs7726552 showed significant association
with AR in our population. Haplotype analysis revealed
a single haplotype block which, when tested for associa-
tion, was significantly different in cases as compared to
controls. This haplotype block, a 4.13 kb region,
includes the 5’ upstream, promoter and the first intron.
The SNP rs7726552 is present in the 5’ upstream region
Figure 1 LD block of the Singapore Chinese population for the UGRP1 gene. Linkage disequilibrium block generated using SNPs identified
in the UGRP1 gene. Figure generated using Haploview 4.1 and the values denoted in the boxes represent R2 values which are a measure of the
linkage between SNP pairs.
Figure 2 LD block generated using tagSNPs genotyped for the
UGRP1 gene. Linkage disequilibrium block generated using
tagSNPs genotyped for the entire study population. Figure
generated using Haploview 4.1 and the values denoted in the
boxes represent R2 values which are a measure of the linkage
between SNP pairs.
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and hence could affect the regulation of gene expression
levels. Previous reports have shown that such poly-
morphisms in the UGRP1 gene could predispose an
individual to allergic inflammation by reducing the levels
of UGRP1 in the airway epithelial cells [19]. Interest-
ingly, the promoter polymorphism G-122A, which was
previously associated with asthma in Japanese people
[19] was also identified in our population and was desig-
nated as UGRP1-G-1351A. However, similar to studies
on Indians and German Caucasians, the association to
asthma for this SNP was not replicated in the Singapore
Chinese population. This could be attributed to underly-
ing differences in the genetic makeup of the populations
evaluated. The evaluation of the influence of rs7726552
on UGRP1 expression and regulation would be helpful
in identifying the role it may play in allergy. Much is
known as to how a gene is regulated and this may
involve multiple potential mechanisms such as differen-
tial gene splicing or binding of transcription factors to
regulatory elements. The presence of SNPs in these reg-
ulatory regions might then predispose an individual to
disease [40,41]. The in silico analysis revealed potential
binding sites for Oct-1, NF-1 and GATA-1 at the 5’
upstream locus where rs7726552 was identified. Oct-1
has been previously shown to be important in regulating
the expression of IL13 which is a key regulator of Th2-
mediated inflammation in allergic diseases. Kiesler et al.,
demonstrated that a polymorphism in the regulatory
element affects the transcription of the IL13 gene by
creating a binding site for Oct-1 [42]. Similarly, Hase-
gawa et al., demonstrated that the T allele on the
Fc epsilon RI alpha-chain promoter introduced an addi-
tional binding motif for GATA-1 compared to the C
allele and hence the transcription activity of the T allele
was enhanced because of the higher affinity for the tran-
scription factor [43]. In a similar fashion, the A to T
change in rs7726552 is predicted to result in the loss of
the binding site for Oct-1 and conversely introduce an
additional binding site for GATA-1. This prediction sug-
gests why the T allele confers protection (OR 0.81) with
a higher proportion of the controls (17%) having the
allele as compared to the cases (14%). The genotyping







Ptrend OR L95 U95
Cases Controls
rs7726552 147235795 T 0.14 0.17 A 0.039* 0.81 0.66 0.98
rs7727031 147236113 C 0.06 0.06 T 0.544 0.91 0.67 1.23
UGRP1-G-1351A 147237116 A 0.07 0.07 G 0.641 1.07 0.81 1.41
rs6882292 147237749 A 0.06 0.06 G 0.739 0.95 0.70 1.28
rs17107353 147239022 A 0.11 0.12 T 0.154 0.85 0.67 1.06
rs17703574 147239339 T 0.05 0.06 G 0.141 0.79 0.56 1.08
UGRP1-C1360A 147239920 A 0.07 0.07 C 0.81 1.04 0.78 1.36
UGRP1-A1846G 147240405 G 0.06 0.06 A 0.687 0.94 0.69 1.27
rs3910207 147241677 T 0.11 0.13 C 0.202 0.87 0.69 1.08
rs34212847 147241803 A 0.07 0.07 G 0.668 1.06 0.80 1.4
Ptrend is calculated by the Cochran Armitage trend test using the PLINK v 1.06 software.
*Ptrend < 0.05 for the association test for AR.
OR - Odds ratio; CI - Confidence Interval.





Model Genotype Case (%) Control (%) c2 P
rs7726552 T A Full genotype TT 16 (2.02) 6 (0.84)
TA 190 (23.93) 227 (31.70)
AA 588 (74.06) 483 (67.46) 7.95 0.00085*
Dominant TT+TA 206 (25.94) 233 (32.54)
AA 588 (74.06) 483 (67.46) 14.13 0.0048#
*P value calculated using c2 test of association for all the three genotypes.
#P value calculated using c2 test of association for a dominant model.
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results showed more evidence for a dominant model of
association producing a Pdominant = 0.0048 and OR =
0.79. The functional significance and the mechanism of
the causal variant in UGRP1 leading to the onset of
allergic rhinitis needs to be confirmed and validated
with further studies.
Haplotype association analysis revealed a common
haplotype on UGRP1 to have significant different fre-
quencies between cases and controls. This haplotype
block contains 7 SNPs from the promoter region and
first intron. Previous reports on the UGRP1 gene have
also confirmed the functionality of haplotype to be asso-
ciated to the promoter region [36] and the regulation of
UGRP1 expression in asthmatic patients [19]. Srisodsai
et al., have shown that in a mouse model, administra-
tion of IL10 increased constitutive UGRP1 mRNA
expression and suggested UGRP1 as a potential target
for IL-10 anti-inflammatory activities in the lung [36].
Chiba et al., demonstrated that UGRP1 can suppress
inflammation in a mouse model for allergic airway
inflammation and also proposed UGRP1 as a therapeutic
candidate for treating lung inflammation [35]. These
reports highlight a potential role for UGRP1 in treat-
ment of allergic airway diseases.
Conclusion
In summary, our study reveals the association of UGRP1
polymorphisms, specifically rs7726552, with allergic rhi-
nitis in the Singapore Chinese population. Haplotype
analysis suggests that multiple polymorphisms in the
gene could be contributing collectively to the pathogen-
esis of AR. Further functional characterization of these
variants would be important in determining if these var-
iants could be used as risk factors for AR.
Additional material
Additional file 1: Gene structure of UGRP1. Figure describing the
structure of the UGRP1 gene on chromosome 5.
Additional file 2: Primers used for sequencing UGRP1 gene. The list
of primers used for sequencing of the UGRP1 gene.
Additional file 3: Summary of polymorphisms identified through
sequencing of UGRP1 gene. Table summarizing the total
polymorphisms identified by sequencing the UGRP1 gene.
Additional file 4: TagSNPs chosen for genotyping for case control
association. The list of SNPs selected for genotyping of the UGRP1 using
the tagging approach.
Additional file 5: Association of UGRP1 SNPs to Asthma phenotype
(Allele based test). Table summarizing the Association of the UGRP1
SNPs calculated using the allele based test for the asthma phenotype.
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